73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers pinpoint tumor-related protein, slow progression of cancers

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.
First-in-class targeted microRNA therapy slows cancer tumor growth

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de
Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

by Jay Furst,Mayo ClinicCredit: AI-generated imageMore than half of all patients who receive solid organ transplants will have an incidence of skin cancer at some point—most often a nonmelanoma

Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

by Jay Furst,Mayo ClinicCredit: AI-generated imageMore than half of all patients who receive solid organ transplants will have an incidence of skin cancer at some point—most often a nonmelanoma
Genetic modifications improve the therapeutic efficacy of iPSC-derived CAR-T cells against solid tumors

Genetic modifications improve the therapeutic efficacy of iPSC-derived CAR-T cells against solid tumors

by Kyoto UniversityThe CAR construct impacts the differentiation of CAR-iPSCs into T-cell lineages. a, Schematic presentation of the CAR constructs 19z, 1928z, 19bbz, 1928bbz and w/oED28z CAR (w/

Genetic modifications improve the therapeutic efficacy of iPSC-derived CAR-T cells against solid tumors

by Kyoto UniversityThe CAR construct impacts the differentiation of CAR-iPSCs into T-cell lineages. a, Schematic presentation of the CAR constructs 19z, 1928z, 19bbz, 1928bbz and w/oED28z CAR (w/
The surprising link between circadian disruption and cancer may have to do with temperature

The surprising link between circadian disruption and cancer may have to do with temperature

byThe Scripps Research InstituteFor mice placed in ‘chronic jet lag’ (CJL) conditions, they showed a 68% increase in tumor burden when compared to mice placed in 12 hours of light, 12 hours of d

The surprising link between circadian disruption and cancer may have to do with temperature

byThe Scripps Research InstituteFor mice placed in ‘chronic jet lag’ (CJL) conditions, they showed a 68% increase in tumor burden when compared to mice placed in 12 hours of light, 12 hours of d
Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical
New therapeutic avenue in the fight against chronic liver disease

New therapeutic avenue in the fight against chronic liver disease

by Ulsan National Institute of Science and TechnologySchematic image showing the ETP expression and survival rate in liver tissue from HCC patients. Credit: UNISTAn international team of research

New therapeutic avenue in the fight against chronic liver disease

by Ulsan National Institute of Science and TechnologySchematic image showing the ETP expression and survival rate in liver tissue from HCC patients. Credit: UNISTAn international team of research
Radiation therapy for patients with breast cancer explained

Radiation therapy for patients with breast cancer explained

by Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainRadiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells

Radiation therapy for patients with breast cancer explained

by Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainRadiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells
CAR T cell immunotherapy for solid tumors? First, you have to break the cancers' sugar shield

CAR T cell immunotherapy for solid tumors? First, you have to break the cancers' sugar shield

by Delthia Ricks , Medical XpressModeling of the impact of tumor N-glycans on the targeting by CAR T cells. Left, the N-glycan decoration of tumors 1) repels CAR T cells by impeding immunological syna

CAR T cell immunotherapy for solid tumors? First, you have to break the cancers' sugar shield

by Delthia Ricks , Medical XpressModeling of the impact of tumor N-glycans on the targeting by CAR T cells. Left, the N-glycan decoration of tumors 1) repels CAR T cells by impeding immunological syna
Novel drug combination shows promise for advanced HER2-negative breast cancer

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a
'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to
Microbiome provides new clues to determining development of colon cancer

Microbiome provides new clues to determining development of colon cancer

by George Washington UniversityCredit: CC0 Public DomainA mutant protein found in humans with colon cancer blocks a pathway that regulates proliferation and expansion of cells, increasing amounts

Microbiome provides new clues to determining development of colon cancer

by George Washington UniversityCredit: CC0 Public DomainA mutant protein found in humans with colon cancer blocks a pathway that regulates proliferation and expansion of cells, increasing amounts